Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial 01/04/2023 15:04 D’Haens et.al.; Clinical Drug Investigation 2023 Apr;43(4):277-288 קרא עוד ←
